本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Silence Therapeutics Plc

5.52
-0.1700-2.99%
盘后5.520.00000.00%15:25 EDT
成交量:2.62万
成交额:14.63万
市值:2.61亿
市盈率:-3.63
高:5.79
开:5.67
低:5.52
收:5.69
数据加载中...
2023/08/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/01

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/03/15

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/10/20

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/22

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/07/20

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/15

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/03/17

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/20

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/29

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/11

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/11

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers